FMP
NASDAQ
0.194 USD
0.0057 (2.94%)
Mr. Stephen S. Yoder J.D.
Healthcare
Biotechnology
https://www.pieris.com
NASDAQ
Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs. The company develops anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins found in human blood plasma and other bodily fluids. Its lead respiratory Anticalin-based drug candidate includes PRS-060/AZD1402, a drug candidate that is in Phase II clinical trial targeting IL-4Ra for the treatment of asthma and other inflammatory diseases; PRS-220, an oral inhaled Anticalin protein targeting connective tissue growth factor for the treatment of idiopathic pulmonary fibrosis; ...
0001583648
US7207951036
720795103
255 State Street
857 246 8998
US
127
Jan 2, 2015
0001583648
NASDAQ
Biotechnology
Healthcare
720795103
US7207951036
US
0.19
0.47
596.15k
19.15M
-
0.136-1.29
2.75
-
-
-
-
-0.57
-
https://www.pieris.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.